A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract

Larry E. Kun, Robert J. Toohill, Paul Y. Holoye, James A. Duncavage, Roger W. Byhardt, Paul S. Ritch, Thomas W. Grossman, Raymond G. Hoffmann, James D. Cox, Tom Malin

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

A prospective, randomized trial of induction chemotherapy in advanced squamous cell carcinomas of the upper aerodigestive tract (UAD) was conducted between July 1979 and September 1982. Eighty-three patients with locally advanced Stage III-IV tumors received standard treatment (STD RX; defined as preoperative irradiation and radical excision or irradiation alone), or induction chemotherapy (CTX) followed by STD RX. Chemotherapy consisted of two cycles of bleomycin (30 units/day by continuous infusions Days 1-4), cyclophosphamide (200 mg/m2 IV Days 1-5), methotrexate (30 mg/m2 Days 1 + 5), and 5-fluorouracil (400 mg/m2 IV Days 1-5). Response to CTX was complete in 2 and partial (>50% reduction) in 27; the overall response rate was 68%. Tumor clearance was documented in 30 40 STD RX patients at completion of irradiation and/or surgery and in 24 43 CTX patients ( 17 29 responders, 7 14 non-responders). Freedom from local-regional disease was noted at 2 years in 53% STD RX and 35% CTX patients (p < .06). CTX patients had a higher proportion of local-regional persistence and recurrence. The difference was apparent only in the subset of patients treated with primary irradiation; local-regional control following irradiation and surgery was equal in STD RX and CTX groups. Survival at 2 years was 43% STD RX and 31% CTX. Disease-free survival in those with clearance was 64% STD RX and 59% CTX. Induction chemotherapy did not improve tumor clearance or survival in this series. Caution regarding local-regional control with CTX and primary irradiation is noted.

Original languageEnglish (US)
Pages (from-to)173-178
Number of pages6
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume12
Issue number2
DOIs
StatePublished - Jan 1 1986

Fingerprint

chemotherapy
Adjuvant Chemotherapy
Sexually Transmitted Diseases
cancer
irradiation
clearances
Induction Chemotherapy
Neoplasms
induction
tumors
surgery
transponders
Survival
Bleomycin
set theory
proportion
Methotrexate
Fluorouracil
Cyclophosphamide
Disease-Free Survival

Keywords

  • Head and neck cancer
  • Induction chemotherapy

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. / Kun, Larry E.; Toohill, Robert J.; Holoye, Paul Y.; Duncavage, James A.; Byhardt, Roger W.; Ritch, Paul S.; Grossman, Thomas W.; Hoffmann, Raymond G.; Cox, James D.; Malin, Tom.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 12, No. 2, 01.01.1986, p. 173-178.

Research output: Contribution to journalArticle

Kun, LE, Toohill, RJ, Holoye, PY, Duncavage, JA, Byhardt, RW, Ritch, PS, Grossman, TW, Hoffmann, RG, Cox, JD & Malin, T 1986, 'A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract', International Journal of Radiation Oncology, Biology, Physics, vol. 12, no. 2, pp. 173-178. https://doi.org/10.1016/0360-3016(86)90090-8
Kun, Larry E. ; Toohill, Robert J. ; Holoye, Paul Y. ; Duncavage, James A. ; Byhardt, Roger W. ; Ritch, Paul S. ; Grossman, Thomas W. ; Hoffmann, Raymond G. ; Cox, James D. ; Malin, Tom. / A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. In: International Journal of Radiation Oncology, Biology, Physics. 1986 ; Vol. 12, No. 2. pp. 173-178.
@article{cc1242ef1d1e45389ba99ae3f5556a16,
title = "A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract",
abstract = "A prospective, randomized trial of induction chemotherapy in advanced squamous cell carcinomas of the upper aerodigestive tract (UAD) was conducted between July 1979 and September 1982. Eighty-three patients with locally advanced Stage III-IV tumors received standard treatment (STD RX; defined as preoperative irradiation and radical excision or irradiation alone), or induction chemotherapy (CTX) followed by STD RX. Chemotherapy consisted of two cycles of bleomycin (30 units/day by continuous infusions Days 1-4), cyclophosphamide (200 mg/m2 IV Days 1-5), methotrexate (30 mg/m2 Days 1 + 5), and 5-fluorouracil (400 mg/m2 IV Days 1-5). Response to CTX was complete in 2 and partial (>50{\%} reduction) in 27; the overall response rate was 68{\%}. Tumor clearance was documented in 30 40 STD RX patients at completion of irradiation and/or surgery and in 24 43 CTX patients ( 17 29 responders, 7 14 non-responders). Freedom from local-regional disease was noted at 2 years in 53{\%} STD RX and 35{\%} CTX patients (p < .06). CTX patients had a higher proportion of local-regional persistence and recurrence. The difference was apparent only in the subset of patients treated with primary irradiation; local-regional control following irradiation and surgery was equal in STD RX and CTX groups. Survival at 2 years was 43{\%} STD RX and 31{\%} CTX. Disease-free survival in those with clearance was 64{\%} STD RX and 59{\%} CTX. Induction chemotherapy did not improve tumor clearance or survival in this series. Caution regarding local-regional control with CTX and primary irradiation is noted.",
keywords = "Head and neck cancer, Induction chemotherapy",
author = "Kun, {Larry E.} and Toohill, {Robert J.} and Holoye, {Paul Y.} and Duncavage, {James A.} and Byhardt, {Roger W.} and Ritch, {Paul S.} and Grossman, {Thomas W.} and Hoffmann, {Raymond G.} and Cox, {James D.} and Tom Malin",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0360-3016(86)90090-8",
language = "English (US)",
volume = "12",
pages = "173--178",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract

AU - Kun, Larry E.

AU - Toohill, Robert J.

AU - Holoye, Paul Y.

AU - Duncavage, James A.

AU - Byhardt, Roger W.

AU - Ritch, Paul S.

AU - Grossman, Thomas W.

AU - Hoffmann, Raymond G.

AU - Cox, James D.

AU - Malin, Tom

PY - 1986/1/1

Y1 - 1986/1/1

N2 - A prospective, randomized trial of induction chemotherapy in advanced squamous cell carcinomas of the upper aerodigestive tract (UAD) was conducted between July 1979 and September 1982. Eighty-three patients with locally advanced Stage III-IV tumors received standard treatment (STD RX; defined as preoperative irradiation and radical excision or irradiation alone), or induction chemotherapy (CTX) followed by STD RX. Chemotherapy consisted of two cycles of bleomycin (30 units/day by continuous infusions Days 1-4), cyclophosphamide (200 mg/m2 IV Days 1-5), methotrexate (30 mg/m2 Days 1 + 5), and 5-fluorouracil (400 mg/m2 IV Days 1-5). Response to CTX was complete in 2 and partial (>50% reduction) in 27; the overall response rate was 68%. Tumor clearance was documented in 30 40 STD RX patients at completion of irradiation and/or surgery and in 24 43 CTX patients ( 17 29 responders, 7 14 non-responders). Freedom from local-regional disease was noted at 2 years in 53% STD RX and 35% CTX patients (p < .06). CTX patients had a higher proportion of local-regional persistence and recurrence. The difference was apparent only in the subset of patients treated with primary irradiation; local-regional control following irradiation and surgery was equal in STD RX and CTX groups. Survival at 2 years was 43% STD RX and 31% CTX. Disease-free survival in those with clearance was 64% STD RX and 59% CTX. Induction chemotherapy did not improve tumor clearance or survival in this series. Caution regarding local-regional control with CTX and primary irradiation is noted.

AB - A prospective, randomized trial of induction chemotherapy in advanced squamous cell carcinomas of the upper aerodigestive tract (UAD) was conducted between July 1979 and September 1982. Eighty-three patients with locally advanced Stage III-IV tumors received standard treatment (STD RX; defined as preoperative irradiation and radical excision or irradiation alone), or induction chemotherapy (CTX) followed by STD RX. Chemotherapy consisted of two cycles of bleomycin (30 units/day by continuous infusions Days 1-4), cyclophosphamide (200 mg/m2 IV Days 1-5), methotrexate (30 mg/m2 Days 1 + 5), and 5-fluorouracil (400 mg/m2 IV Days 1-5). Response to CTX was complete in 2 and partial (>50% reduction) in 27; the overall response rate was 68%. Tumor clearance was documented in 30 40 STD RX patients at completion of irradiation and/or surgery and in 24 43 CTX patients ( 17 29 responders, 7 14 non-responders). Freedom from local-regional disease was noted at 2 years in 53% STD RX and 35% CTX patients (p < .06). CTX patients had a higher proportion of local-regional persistence and recurrence. The difference was apparent only in the subset of patients treated with primary irradiation; local-regional control following irradiation and surgery was equal in STD RX and CTX groups. Survival at 2 years was 43% STD RX and 31% CTX. Disease-free survival in those with clearance was 64% STD RX and 59% CTX. Induction chemotherapy did not improve tumor clearance or survival in this series. Caution regarding local-regional control with CTX and primary irradiation is noted.

KW - Head and neck cancer

KW - Induction chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=0022636206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022636206&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(86)90090-8

DO - 10.1016/0360-3016(86)90090-8

M3 - Article

VL - 12

SP - 173

EP - 178

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -